MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.beha.2013.07.010

Медицинская библиотека · Best practice & research. Clinical haematology · 2013

New developments in parenteral anticoagulation for arterial and venous thromboembolism.

van Es Nick, Bleker Suzanne M, Büller Harry R, Coppens Michiel

СтатьяОбзорПеревод пока не подготовлен

Аннотация

The efficacy and safety of heparin and low-molecular-weight heparins (LMWHs) are well documented in venous and arterial thromboembolism. Several drawbacks of heparins have inspired the development of newer parenteral anticoagulants for specific indications, including heparin-induced thrombocytopenia (HIT) and percutaneous coronary interventions (PCI). The direct thrombin inhibitors recombinant hirudin and argatroban are now established alternatives for HIT patients, and bivalirudin is one of the most used anticoagulants in PCI. The pentasaccharide fondaparinux is an alternative for LMWH for thromboprophylaxis in various clinical settings and for patients with an acute coronary syndrome (ACS) not scheduled for PCI. In Europe, it was recently approved for treatment of superficial vein thrombosis. Further development of new parenteral anticoagulants is slow and the emphasis has shifted towards development of new oral anticoagulants and antiplatelet drugs. Still, promising new anticoagulants, some targeting less conventional targets in the coagulation system, have been developed and will undergo further clinical evaluation.

Для цитирования: van Es Nick, Bleker Suzanne M, Büller Harry R, Coppens Michiel. New developments in parenteral anticoagulation for arterial and venous thromboembolism.. Best practice & research. Clinical haematology. 2013. DOI: 10.1016/j.beha.2013.07.010.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.